Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces an NIH transition update, including that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T05:28:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T04:45:07.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T08:17:56.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now includes the study documents (SAP, Study Protocol) and IPD sharing plan, along with related metadata updates, which contextualize the trial's methodology and governance.
    Difference
    80%
    Check dated 2026-09-27T07:54:16.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added, and the page's Study Documents section was significantly reduced, removing items such as Statistical Analysis Plan and Study Protocol.
    Difference
    18%
    Check dated 2026-09-20T03:12:00.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page, indicating a software version increment. No visible changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-08-29T23:55:40.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.